Intensity TherapeuticsINTS
13F holders, Q2 2026 (June 30)17holders +3
4new positions
1sold out
$4.10avg. 13F price*
At the end of Q2 2026, 17 institutions reported holding Intensity Therapeutics Inc. (INTS) in their 13F filings, up 3 from Q1 2026. 4 opened new positions and 1 sold out. The largest holders were Kingsbury Capital Investment Advisors LLC ($2.0M), KMT Wealth Management, LLC ($2.0M) and Rothschild Wealth LLC ($110K).
- Company
- Intensity Therapeutics Inc.
- CUSIP
- 45828J202
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $2.1M |
| Exits | 1 | $1K |
All 13F filers, Q1 2026 → Q2 2026: 992,054 shares bought and 3,623 shares sold, net +988,431 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| Kingsbury Capital Investment Advisors LLC | 1.72% | Add +1204.7% | 496,493 | $2.0M |
| KMT Wealth Management, LLC | 1.72% | New | 496,493 | $2.0M |
| Rothschild Wealth LLC | 0.01% | Add +14.7% | 26,723 | $110K |
| Vanguard Capital Management LLC | 0.00% | Add +57.8% | 26,569 | $109K |
| Sapient Capital LLC | 0.00% | No change | 26,006 | $107K |
| Nano Cap New Millennium Growth Fund L P | 0.08% | No change | 25,000 | $103K |
| Geode Capital Management, LLC | 0.00% | Reduce -12.4% | 22,787 | $93K |
| FNY Investment Advisers, LLC | 0.03% | New | 22,000 | $90K |
| Mesirow Financial Investment Management, Inc. | 0.00% | No change | 14,118 | $58K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 9,121 | $37K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +2861.2% | 1,984 | $8K |
| NewEdge Advisors, LLC | 0.00% | No change | 1,148 | $5K |
| Osaic Holdings, Inc. | 0.00% | No change | 200 | $820 |
| Barclays PLC | 0.00% | New | 42 | $172 |
| Morgan Stanley | 0.00% | No change | 20 | $82 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 6 | $25 |
| UBS Group AG | 0.00% | Reduce -99.5% | 1 | $4 |
"% of holder's portfolio" is INTS's weight in each manager's 13F, not the share of Intensity Therapeutics Inc. the manager owns.